Avantax Advisory Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.62M Buy
109,029
+4,960
+5% +$347K 0.04% 331
2025
Q1
$7.65M Buy
104,069
+2,173
+2% +$160K 0.05% 307
2024
Q4
$6.68M Sell
101,896
-5,481
-5% -$359K 0.04% 320
2024
Q3
$8.37M Buy
107,377
+4,949
+5% +$386K 0.05% 271
2024
Q2
$7.99M Buy
102,428
+71,222
+228% +$5.55M 0.06% 251
2024
Q1
$2.11M Buy
31,206
+4,197
+16% +$284K 0.02% 530
2023
Q4
$1.82M Sell
27,009
-185
-0.7% -$12.5K 0.02% 532
2023
Q3
$1.84M Sell
27,194
-797
-3% -$54K 0.02% 483
2023
Q2
$2M Sell
27,991
-3,015
-10% -$216K 0.02% 451
2023
Q1
$2.15M Sell
31,006
-2,792
-8% -$194K 0.03% 420
2022
Q4
$2.29M Buy
33,798
+2,939
+10% +$199K 0.03% 380
2022
Q3
$1.69M Sell
30,859
-23
-0.1% -$1.26K 0.03% 409
2022
Q2
$2.04M Buy
30,882
+1,693
+6% +$112K 0.03% 374
2022
Q1
$1.94M Sell
29,189
-2,310
-7% -$153K 0.03% 382
2021
Q4
$1.84M Buy
31,499
+284
+0.9% +$16.5K 0.03% 383
2021
Q3
$1.87M Sell
31,215
-1,831
-6% -$110K 0.03% 351
2021
Q2
$1.98M Sell
33,046
-2,752
-8% -$165K 0.04% 326
2021
Q1
$1.78M Buy
35,798
+133
+0.4% +$6.61K 0.04% 309
2020
Q4
$1.78M Sell
35,665
-24,824
-41% -$1.24M 0.04% 289
2020
Q3
$3.31M Buy
60,489
+17,643
+41% +$965K 0.05% 264
2020
Q2
$2.27M Buy
42,846
+144
+0.3% +$7.61K 0.07% 202
2020
Q1
$1.91M Buy
42,702
+5,048
+13% +$226K 0.06% 200
2019
Q4
$1.88M Buy
37,654
+4,307
+13% +$215K 0.04% 220
2019
Q3
$1.49M Buy
33,347
+3,692
+12% +$165K 0.06% 159
2019
Q2
$1.22M Buy
29,655
+5,754
+24% +$237K 0.05% 166
2019
Q1
$966K Buy
23,901
+2,226
+10% +$90K 0.05% 181
2018
Q4
$820K Buy
+21,675
New +$820K 0.14% 153